Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marc Silver

Sports Medicine Stuart, FL Medical Doctor

NPI 1528155918 CMS profile 114176

2150 Se Salerno Rd Ste 110, Stuart, FL 34997

Open in the dashboard

General payments

$31,677

42 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marc Silver of Stuart, FL is reported in the CMS Open Payments database as having received $31,677 across 42 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $312 5
2024 General $2,020 2
2023 General $26,621 18
2021 General $2,229 11
2020 General $170 1
2019 General $326 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marc Silver
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Marc Silver were reported at $312. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Marc Silver Sports Medicine median Middle half National median
2019 $326 $1,176 $199–$4,249 $163
2020 $170 $708 $96–$2,890 $114
2021 $2,229 $1,213 $152–$3,994 $132
2022 $0 $1,230 $159–$3,998 $149
2023 $26,621 $584 $146–$2,836 $160
2024 $2,020 $628 $163–$3,168 $164
2025 $312 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Think Surgical, Inc. $28,317 14 payments
  2. Arthrex, Inc. $1,412 3 payments
  3. Stryker Corporation $805 10 payments
  4. Smith+Nephew, Inc. $423 5 payments
  5. Gotham Surgical Solutions & Devices, Inc. $351 2 payments
  6. Southern Edge Orthopaedics, Inc. $134 1 payment
  7. Bioventus LLC $60 2 payments
  8. Kairos Surgical Inc $58 1 payment
  9. Zimmer Biomet Holdings, Inc. $58 1 payment
  10. Avanos Medical $22 1 payment
  11. Other $37 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,000 3 payments
  2. Travel and Lodging $11,680 9 payments
  3. Food and Beverage $1,797 29 payments
  4. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. TMINI Miniature Robotic System $28,317 14 payments
  2. PERFORMANCE SOLUTIONS $227 3 payments
  3. TRIATHLON $170 1 payment
  4. POLARCUP $170 2 payments
  5. LEGION $150 1 payment
  6. MAKO $148 3 payments
  7. GAMMA $144 1 payment
  8. AXSOS $144 1 payment
  9. CORI $128 1 payment
  10. OR3O $128 1 payment
  11. Other $587 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

133

Median for Orthopedic Surgery: 203

Drug cost

$1,207

Median for Orthopedic Surgery: $1,433

Branded share of claims

25.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 14 $378
Celecoxib Generic 32 $262
Nabumetone Generic 30 $210
Meloxicam Generic 23 $175
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 22 $137
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $45

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$103,151

Of which drugs: $11,427

Medicare patients

316

Average age 77

Services billed

1,544

196 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 64%
Ischemic heart disease 30%
Diabetes 27%
Depression 25%
Osteoporosis 24%
Atrial fibrillation 23%
Heart failure 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 19 59 $5,363
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 78 175 $937

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

42 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record